PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--July 20, 2006--Beijing Med-Pharm Corporation (BJGP.OB) today announced that it has entered an agreement with Taiwan Biotech Co., Ltd. to serve as the exclusive distributor of ritodrine hydrochloride (trade name Anpo), a treatment for preterm labor, in mainland China. Under the terms of the agreement, Beijing Med-Pharm will also provide sales and marketing support for the product.
